Skip to main content

Advertisement

Log in

Photodynamic Antifungal Therapy Against Chromoblastomycosis

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Photodynamic therapy (PDT) is a minimally invasive approach, in which a photosensitizer compound is activated by exposure to light. The activation of the sensitizer drug results in several chemical reactions, such as the production of reactive oxygen species and other reactive molecules, which presence in the biological site leads to the damage of target cells. Although PDT has been primarily developed to combat cancerous lesions, this therapy can be employed for the treatment of several conditions, including infectious diseases. A wide range of microorganisms, including Gram-positive and Gram-negative bacteria, viruses, protozoa, and fungi, have demonstrated susceptibility to antimicrobial PDT. This treatment might consist in an alternative for the management of fungal infections. Antifungal photodynamic therapy has been successfully employed against Candida species, dermatophytes, and Aspergillus niger. Chromoblastomycosis is an infection that involves skin and subcutaneous tissues caused by the traumatic inoculation of dematiaceous fungi species, being that the most prevalent are Fonsecaea pedrosoi and Claphialophora carrionii. In the present work, the clinical applications of PDT for the treatment of chromoblastomycosis are evaluated. We have employed methylene blue as photosensitizer and a LED (Light Emitting Diode) device as light source. The results of this treatment are positive, denoting the efficacy of PDT against chromoblastomycosis. Considering that great part of the published works are focused on in vitro trials, these clinical tests can be considered a relevant source of information about antifungal PDT, since its results have demonstrated to be promising. The perspectives of this kind of treatment are analyzed in agreement with the recent literature involving antifungal PDT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Moreira LM, Santos FV, Lyon JP, Maftoum-Costa M, Pacheco-Soares C, Silva NS. Photodynamic therapy: porphyrins and phthalocyanines as photosensitizers. Aus J Chem. 2008;61:741–54.

    Article  CAS  Google Scholar 

  2. Calzavara-Pinton PG, Venturini M, Sala R. A comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobiol B: Biol. 2005;78:1–6.

    Article  CAS  Google Scholar 

  3. Zeina B, Greenman J, Purcell WM, Das B. Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol. 2001;144:274–8.

    Article  PubMed  CAS  Google Scholar 

  4. Zeina B, Greenman J, Corry D, Purcell WM. Cytotoxic effects of antimicrobial photodynamic therapy on keratinocytes in vitro. Br J Dermatol. 2002;146:568–73.

    Article  PubMed  CAS  Google Scholar 

  5. Zeina B, Greenman J, Corry D, Purcell WM. Antimicrobial photodynamic therapy: assessment of genotoxic effects on keratinocytes in vitro. Br J Dermatol. 2003;148:229–32.

    Article  PubMed  CAS  Google Scholar 

  6. Marotti J, Aranha AC, Eduardo Cde P, Ribeiro MS. Photodynamic therapy can be effective as a treatment for herpes simplex labialis. Photomed Laser Surg. 2009;27:357–63.

    Article  PubMed  Google Scholar 

  7. Rossi R, Bruscino N, Ricceri F, Grazzini M, Dindelli M, Lotti T. Photodynamic treatment for viral infections of the skin. G Ital Dermatol Venereol. 2009;144:79–83.

    PubMed  CAS  Google Scholar 

  8. Kacerovska D, Pizinger K, Kumpova M, Cetkovska P. Genital warts treated by photodynamic therapy. Skinmed. 2007;6:295–7.

    Article  PubMed  Google Scholar 

  9. Akilov OE, Kosaka S, O’Riordan K, Hasan T. Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells. Exp Dermatol. 2007;16:651–60.

    Article  PubMed  CAS  Google Scholar 

  10. Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol. 2006;31:634–7.

    Article  PubMed  CAS  Google Scholar 

  11. Bristow C, Hudson R, Paget TA, Boyle RW. Potential of cationic porphyrins for photodynamic treatment of cutaneous leishmaniasis. Photodiag Photodyn Ther. 2006;3:162–7.

    Article  CAS  Google Scholar 

  12. Akilov OE, Kosaka S, O’Riordan K, Hasan T. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation. Photochem Photobiol Sci. 2007;6:1067–75.

    Article  PubMed  CAS  Google Scholar 

  13. Silva NS, de Ribeiro CM, Machado AH, Pacheco-Soares C. Ultrastructural changes in T. foetus after treatments with AlPcS4 and photodynamic therapy. Vet Parasitol. 2007;146:175–81.

    Article  PubMed  Google Scholar 

  14. Bliss JM, Bigelow CE, Foster TH, Haidaris CG. Susceptibility of Candida species to photodynamic effects of photofrin. Antimicrob Agents Chemother. 2004;48:2000–6.

    Article  PubMed  CAS  Google Scholar 

  15. Munin E, Giroldo LM, Alves LP, Costa MS. Study of germ tube formation by C. albicans after photodynamic antimicrobial chemotherapy (PACT). J Photochem Photobiol B: Biol. 2007;88:16–20.

    Article  CAS  Google Scholar 

  16. Giroldo LM, Felipe MP, Oliveira MA, Munin E, Alves LP, Costa MS. Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in C. albicans. Lasers Med Sci. 2009;24:109–12.

    Article  PubMed  Google Scholar 

  17. Dovigo LN, Pavarina AC, Oliveira M, Garcia E, Giampaolo ET, Vergani CE, Bagnato VS. Fungicidal effect of photodynamic therapy against fluconazole-resistant C. albicans and C. glabrata. Mycoses. 2009;54:123–30.

    Article  Google Scholar 

  18. Calzavara-Pinton PG, Venturini M, Capezzera R, Sala R, Zane C. Photodynamic therapy of interdigital mycoses of the feet with topical application of 5-aminolevulinic acid. Photodermatol Photoimmunol Photomed. 2004;20:144–7.

    Article  PubMed  CAS  Google Scholar 

  19. Smijs TGM, Schuitmaker HJ. Photodynamic Inactivation of the dermatomycete T. rubrum. Photochem Photobiol. 2003;77:556–60.

    Article  PubMed  CAS  Google Scholar 

  20. Friedberg JS, Skema C, Baum ED, Burdick J, Vinogradov SA, Wilson DF, Horan AD, Nachamkin I. In vitro effects of photodynamic therapy on A. fumigatus. J Antimicrob Chemother. 2001;48:105–7.

    Article  PubMed  CAS  Google Scholar 

  21. Donnelly RF, McCarron PA, Tunney MM. Antifungal photodynamic therapy. Microbiol Res. 2008;163:1–12.

    Article  PubMed  CAS  Google Scholar 

  22. Qiao J, Li R, Ding Y, Fang H. Photodynamic therapy in the treatment of superficial mycoses: an evidence-based evaluation. Mycopathologia. 2010;170:339–43.

    Article  PubMed  Google Scholar 

  23. Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009;47:3–15.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juliana Pereira Lyon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lyon, J.P., de Maria Pedroso e Silva Azevedo, C., Moreira, L.M. et al. Photodynamic Antifungal Therapy Against Chromoblastomycosis. Mycopathologia 172, 293–297 (2011). https://doi.org/10.1007/s11046-011-9434-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-011-9434-6

Keywords

Navigation